ID

36289

Description

Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy; ODM derived from: https://clinicaltrials.gov/show/NCT02056548

Link

https://clinicaltrials.gov/show/NCT02056548

Keywords

  1. 4/30/19 4/30/19 -
  2. 9/20/21 9/20/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

April 30, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lymphoma NCT02056548

Eligibility Lymphoma NCT02056548

  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT02056548
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
18 years old or older
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status 0, 1, 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
hodgkin's or non-hodgkins lymphomas according to the who 2008 classification
Description

Hodgkin Lymphoma WHO tumor classification | Non-Hodgkin Lymphoma WHO tumor classification

Data type

boolean

Alias
UMLS CUI [1,1]
C0019829
UMLS CUI [1,2]
C1301142
UMLS CUI [2,1]
C0024305
UMLS CUI [2,2]
C1301142
patients who received standard cytotoxic chemotherapies
Description

Cytotoxic Chemotherapy Standard

Data type

boolean

Alias
UMLS CUI [1,1]
C0677881
UMLS CUI [1,2]
C1442989
patients who finished chemotherapy (duration not exceeded 6 months) or who will finish the planned chemotherapy
Description

Chemotherapy Discontinued | Chemotherapy Planned To be stopped

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1444662
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C1301732
UMLS CUI [2,3]
C1272691
patients who achieved at least partial response and do not need further chemotherapy
Description

Partial response | Response | Chemotherapy Discontinued

Data type

boolean

Alias
UMLS CUI [1]
C1521726
UMLS CUI [2]
C1704632
UMLS CUI [3,1]
C0392920
UMLS CUI [3,2]
C1444662
hbsag (+) patients who received preemptive antiviral therapies
Description

Hepatitis B surface antigen positive | Antiviral Therapy

Data type

boolean

Alias
UMLS CUI [1]
C0149709
UMLS CUI [2]
C0280274
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
anti-hcv ab(+), hiv(+), or autoimmune hepatitis
Description

Hepatitis C antibody positive | HIV Seropositivity | Hepatitis, Autoimmune

Data type

boolean

Alias
UMLS CUI [1]
C0281863
UMLS CUI [2]
C0019699
UMLS CUI [3]
C0241910
complications due to uncompensated liver cirrhosis
Description

Complications Due to Liver Cirrhosis Uncompensated

Data type

boolean

Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0023890
UMLS CUI [1,4]
C0205433
child pugh score : 10 points or more
Description

Child-Pugh Classification

Data type

boolean

Alias
UMLS CUI [1]
C2347612
hepatocellular carcinoma
Description

Liver carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C2239176
patients who finish the lymphoma treatments with only radiotherapy
Description

Therapeutic radiology procedure Discontinued Lymphoma

Data type

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C0024299

Similar models

Eligibility Lymphoma NCT02056548

  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT02056548
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
18 years old or older
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0, 1, 2
boolean
C1520224 (UMLS CUI [1])
Hodgkin Lymphoma WHO tumor classification | Non-Hodgkin Lymphoma WHO tumor classification
Item
hodgkin's or non-hodgkins lymphomas according to the who 2008 classification
boolean
C0019829 (UMLS CUI [1,1])
C1301142 (UMLS CUI [1,2])
C0024305 (UMLS CUI [2,1])
C1301142 (UMLS CUI [2,2])
Cytotoxic Chemotherapy Standard
Item
patients who received standard cytotoxic chemotherapies
boolean
C0677881 (UMLS CUI [1,1])
C1442989 (UMLS CUI [1,2])
Chemotherapy Discontinued | Chemotherapy Planned To be stopped
Item
patients who finished chemotherapy (duration not exceeded 6 months) or who will finish the planned chemotherapy
boolean
C0392920 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C1272691 (UMLS CUI [2,3])
Partial response | Response | Chemotherapy Discontinued
Item
patients who achieved at least partial response and do not need further chemotherapy
boolean
C1521726 (UMLS CUI [1])
C1704632 (UMLS CUI [2])
C0392920 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
Hepatitis B surface antigen positive | Antiviral Therapy
Item
hbsag (+) patients who received preemptive antiviral therapies
boolean
C0149709 (UMLS CUI [1])
C0280274 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Hepatitis C antibody positive | HIV Seropositivity | Hepatitis, Autoimmune
Item
anti-hcv ab(+), hiv(+), or autoimmune hepatitis
boolean
C0281863 (UMLS CUI [1])
C0019699 (UMLS CUI [2])
C0241910 (UMLS CUI [3])
Complications Due to Liver Cirrhosis Uncompensated
Item
complications due to uncompensated liver cirrhosis
boolean
C0009566 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0023890 (UMLS CUI [1,3])
C0205433 (UMLS CUI [1,4])
Child-Pugh Classification
Item
child pugh score : 10 points or more
boolean
C2347612 (UMLS CUI [1])
Liver carcinoma
Item
hepatocellular carcinoma
boolean
C2239176 (UMLS CUI [1])
Therapeutic radiology procedure Discontinued Lymphoma
Item
patients who finish the lymphoma treatments with only radiotherapy
boolean
C1522449 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial